Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and WebcastConference Call
CELC Stock | USD 13.05 0.85 6.12% |
About 66% of Celcuity LLC's investor base is looking to short. The analysis of the overall investor sentiment regarding Celcuity LLC suggests that many traders are alarmed. The current market sentiment, together with Celcuity LLC's historical and current headlines, can help investors time the market. In addition, many technical investors use Celcuity LLC stock news signals to limit their universe of possible portfolio assets.
Celcuity |
MINNEAPOLIS, March 20, 2024 -- Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted...
Read at globenewswire.com
Celcuity LLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Celcuity LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Celcuity LLC Fundamental Analysis
We analyze Celcuity LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celcuity LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celcuity LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Celcuity LLC is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Celcuity LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celcuity LLC stock to make a market-neutral strategy. Peer analysis of Celcuity LLC could also be used in its relative valuation, which is a method of valuing Celcuity LLC by comparing valuation metrics with similar companies.
Peers
Celcuity LLC Related Equities
ANAB | AnaptysBio | 4.77 | ||||
ANTX | AN2 Therapeutics | 3.73 | ||||
CSBR | Champions Oncology | 3.59 | ||||
ACRV | Acrivon Therapeutics, | 2.65 | ||||
MNOV | MediciNova | 1.46 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
MOLN | Molecular Partners | 0.53 | ||||
EWTX | Edgewise Therapeutics | 0.31 | ||||
IKNA | Ikena Oncology | 1.16 | ||||
MLYS | Mineralys Therapeutics, | 1.42 | ||||
RZLT | Rezolute | 1.44 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
ADAG | Adagene | 2.20 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
CCCC | C4 Therapeutics | 4.34 |
Complementary Tools for Celcuity Stock analysis
When running Celcuity LLC's price analysis, check to measure Celcuity LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celcuity LLC is operating at the current time. Most of Celcuity LLC's value examination focuses on studying past and present price action to predict the probability of Celcuity LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celcuity LLC's price. Additionally, you may evaluate how the addition of Celcuity LLC to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |